Malignant neoplasm of right main bronchus
ICD-10 C34.01 is a billable code used to indicate a diagnosis of malignant neoplasm of right main bronchus.
C34.01 refers to a malignant neoplasm located in the right main bronchus, which is a critical airway structure leading to the right lung. This type of lung cancer is often associated with significant morbidity and mortality, primarily due to its aggressive nature and late presentation. Risk factors include a history of smoking, exposure to environmental pollutants, and genetic predispositions. Symptoms may include persistent cough, hemoptysis, chest pain, and dyspnea. Diagnosis typically involves imaging studies such as chest X-rays and CT scans, followed by bronchoscopy for biopsy confirmation. Staging is crucial for determining the extent of disease and guiding treatment, which may include surgical resection, chemotherapy, and radiation therapy. Molecular markers, such as EGFR mutations and ALK rearrangements, play a vital role in personalized treatment approaches, particularly in non-small cell lung cancer (NSCLC) cases. Understanding the nuances of this diagnosis is essential for accurate coding and optimal patient management.
Detailed treatment plans, staging information, and molecular testing results.
Management of newly diagnosed lung cancer patients, follow-up for treatment response.
Ensure accurate coding of treatment modalities and staging.
Pulmonary function tests, imaging studies, and symptom assessments.
Evaluation of patients with respiratory symptoms and suspected lung cancer.
Documenting the patient's smoking history and environmental exposures is critical.
Used for biopsy confirmation in suspected lung cancer cases.
Document indication for bronchoscopy and findings.
Pulmonology specialists should ensure accurate reporting of findings.
Staging is crucial as it determines treatment options and prognosis. Accurate staging documentation is essential for proper coding and reimbursement.
